
With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.

With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.
BD and Waters plan to spin off BD’s biosciences and diagnostics unit and merge it with Waters. The deal targets a Feb. 9 closing, with BD shareholders set to hold about 39.2% of the combined company after the merger; Waters will issue stock to fund the deal. The spin-off record date is Feb. 5. The…